Rafeh Naqash: Fantastic discussion on biomarker testing and precison oncology
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, replied to the post of Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, on X/Twitter:
”We are now expanding to 56 more for MSS CRC (total n=77).
- 30 for rectal MSS.
- 15 total for MSI-High.
I treated 11 patients with BOT/BAL this week neoadjuvant. Tides are changing! Thank you for the shoutout!”
Quoting Rafeh Naqash‘s post:
”Fantastic discussion on biomarker testing and precison oncology . GI cancer discussion now led by Ignacio Garrido-Laguna, Sunnie Kim and talking about Pashtoon Kasi trial in MSS CRC with ICI!”
Source: Rafeh Naqash/X and Pashtoon Kasi/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023